VEVFX
Price
$46.06
Change
-$0.89 (-1.90%)
Updated
Sep 6 closing price
VSCPX
Price
$307.28
Change
-$4.80 (-1.54%)
Updated
Sep 6 closing price
Ad is loading...

VEVFX vs VSCPX

Header iconVEVFX vs VSCPX Comparison
Open Charts VEVFX vs VSCPXBanner chart's image
Vanguard Explorer Value I
Price$46.06
Change-$0.89 (-1.90%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index InstlPlus
Price$307.28
Change-$4.80 (-1.54%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VEVFX vs VSCPX Comparison Chart
Loading...
VS
VEVFX vs. VSCPX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEVFX is a StrongSell and VSCPX is a Buy.

FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 149B vs. VEVFX (1.12B). VEVFX pays higher dividends than VSCPX: VEVFX (1.61) vs VSCPX (1.44). VEVFX was incepted earlier than VSCPX: VEVFX (14 years) vs VSCPX (14 years). VEVFX is a more actively managed with annual turnover of: 23.00 vs. VSCPX (12.00). VEVFX has a lower initial minimum investment than VSCPX: VEVFX (3000) vs VSCPX (100000000). VEVFX annual gain was more profitable for investors over the last year : 16.22 vs. VSCPX (14.28). VSCPX return over 5 years is better than : 49.02 vs. VEVFX (39.57).
VEVFXVSCPXVEVFX / VSCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years14 years-
Gain YTD9.0855.994152%
Front LoadN/AN/A-
Min. Initial Investment30001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B149B1%
Annual Yield % from dividends1.611.44112%
Returns for 1 year16.2214.28114%
Returns for 3 years1.46-0.33-437%
Returns for 5 years39.5749.0281%
Returns for 10 years44.95103.6343%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPP49.212.73
+5.87%
WPP PLC
ACR15.670.20
+1.29%
ACRES Commercial Realty Corp
RGNX11.380.10
+0.89%
REGENXBIO
ATXI2.80-0.01
-0.36%
Avenue Therapeutics
ALKT31.12-0.37
-1.17%
Alkami Technology